Abstract
We studied combined effect of β-hairpin antimicrobial peptide tachyplesin I and cytotoxic agent cisplatin on tumor and normal human cell lines. MTT assay and flow cytometry showed that tachyplesin I selectively sensitized cancer cells to cisplatin in specified concentration ratios. In vitro experiments demonstrated that combined use of tachyplesin I and cisplatin allows decreasing the effective dose of the cytostatic thus reducing nonspecific toxicity.
Keywords:
antimicrobial peptide; cisplatin; cytotoxicity; effective dose; tachyplesin.
MeSH terms
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents / pharmacology
-
Antimicrobial Cationic Peptides / administration & dosage
-
Antimicrobial Cationic Peptides / pharmacology*
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Cell Proliferation / drug effects
-
Cells, Cultured
-
Cisplatin / administration & dosage
-
Cisplatin / pharmacology*
-
DNA-Binding Proteins / administration & dosage
-
DNA-Binding Proteins / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Interactions
-
Drug Screening Assays, Antitumor
-
HEK293 Cells
-
HL-60 Cells
-
Humans
-
Neoplasms / pathology*
-
Peptides, Cyclic / administration & dosage
-
Peptides, Cyclic / pharmacology*
Substances
-
Anti-Infective Agents
-
Antimicrobial Cationic Peptides
-
DNA-Binding Proteins
-
Peptides, Cyclic
-
tachyplesin peptide, Tachypleus tridentatus
-
Cisplatin